Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.

Zhao, Zhihan

Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. [electronic resource] - Clinical pharmacology and therapeutics 09 2019 - 642-651 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1532-6535

10.1002/cpt.1449 doi


Action Potentials--drug effects
Arrhythmias, Cardiac
Cardiovascular Agents--pharmacology
Dose-Response Relationship, Drug
ERG1 Potassium Channel--metabolism
Epinephrine--pharmacology
Heart Conduction System--abnormalities
Heart Defects, Congenital
Humans
Induced Pluripotent Stem Cells--drug effects
Myocytes, Cardiac--drug effects